SECTION

#Gene Therapy

Total 2 related articles

Live wire →

NewsTag

Featured

Taysha Gene Therapies Plunges on $200M Stock Offering at $6 Per Share

Lead report

美股

Lead report

Taysha Gene Therapies Plunges on $200M Stock Offering at $6 Per Share

Taysha Gene Therapies announced a $200 million public offering at $6 per share, causing a sharp after-hours selloff. The article analyzes the dilutive financing, pipeline progress, and investor concerns.

YayaNews2026-06-25 14:433 min

来源: Seeking Alpha

美股

Syntax Bio Closes $14.4M Series A, Adds New CBO and Board Members

Gene editing company Syntax Bio expands its Series A to $14.4 million, appoints a new Chief Business Officer and two independent directors. Funds will advance metabolic disease gene therapy pipeline and technology platform.

YayaNews2026-06-22 04:363 min来源: Seeking Alpha

Syntax Bio Closes $14.4M Series A, Adds New CBO and Board Members

Featured

Taysha Gene Therapies Plunges on $200M Stock Offering at $6 Per Share

Syntax Bio Closes $14.4M Series A, Adds New CBO and Board Members

More Related Articles